MAP7 and ovarian carcinoma: This finding not only contributes to our understanding of MAP7's functional repertoire but also highlights its potential as a pivotal factor in cancer drug resistance, opening avenues for targeted therapeutic strategies against ovarian cancer and possibly other malignancies exhibiting chemoresistance.